Madeline McKinnon
Associate - Class Actions
Contact MadelineMadeline is an associate lawyer who focuses on complex pharmaceutical and medical device class actions.
Education
University of Ottawa
Western University
About
Madeline is an associate lawyer in Siskinds’ class actions department. Her practice is centered around the prosecution of complex pharmaceutical and medical device class actions.
Prior to law school, Madeline obtained her Bachelor of Science in Nursing from Western University, where she graduated with distinction and made the Dean’s Honour List. Madeline briefly practiced as a nurse in long-term care and public health.
Madeline obtained her J.D. from the University of Ottawa, Faculty of Law in 2014. Madeline graduated cum laude, in the top 5% of her program. While in law school, she was a Dean’s Legal Writing and Research Fellow, and clerked for the Health Professions Appeal and Review Board (“HPARB”). Madeline has a strong interest in health law.
Client Testimonials
Thank you so much for caring
I am certainly grateful for Jill McCartney and Madeline McKinnon for all the time they spent on the class action for my and many others issue. People like me do not understand all the legal procedures and get impatient but the team was there to answer any questions or concerns no matter how many times I called or e-mailed and encouraged me to do so. In the end Jill made sure I totally understood the decisions. Thank you so much for caring. Would recommend this firm anytime. - F.A.
Memberships and Associations
Law Society of Upper Canada, Member
Community Involvement
London Food Bank Board of Directors, Vice Chair
Neighbourhood Legal Services (London and Middlesex) Board of Directors, Past Vice Chair
Blog Posts By Madeline McKinnon
- Speeding up Certification by Extending Filing Deadlines?
- Got Spam? What you can do if you are receiving unwanted e-mails.
- Endean v British Columbia: efficient and economic access to justice for Canadian class members
- Zofran: A Drug Manufacturer’s Duty to Warn
- Zofran: The Dangers of Off-Label Drug Use